This study aims to introduce a new dietary therapy for Eosinophilic Esophagitis (EoE) patients by using partial enteral nutrition (PEN) to enhance remission rates and explore how this approach affects immune function, gut microbiota, and environmental toxin exposures.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility of PEN assessed by 3-day diet record
Timeframe: 3 months
Tolerability of PEN in EoE patients will be assessed by stool quality evaluated using the Bristol Stool Chart.
Timeframe: 3 months
Clinical and endoscopic remission rates assessed by mucosal eosinophilia and Eosinophilic Esophagitis Histology Scoring System (EoE-HSS) from GI tissue biopsies
Timeframe: 3 months
Immune profiles assessed by blood markers
Timeframe: 3 months
Microbiota shifts in EoE patients
Timeframe: 3 months
Environmental contaminants assessed by blood serum levels
Timeframe: 3 months